In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Horizon Therapeutics plc

https://www.horizontherapeutics.com

Latest From Horizon Therapeutics plc

Horizon Provides Assurances That Tepezza Sales Are Set To Soar

Sales of the thyroid eye disease drug were impacted by surging COVID-19 case numbers in the first quarter, but the company is expanding its commercial team to capitalize on new TED market insights. 

Launches Growth

Lots To Celebrate Among 2021 Drug Launches, But Underlying Trends Underwhelm

The number of new drugs that launched in 2021 was on par with recent high trends, but launch trajectories generally underwhelmed commercially – except for COVID-19 vaccines.

Launches Scrip Perspectives

Merck KGaA Ties Up Chord To Advance Cladribine Rare Disease Programs

Merck will develop Chord’s lead drug candidate, an oral version of cladribine, for the treatment of neuromyelitis optica spectrum disorders and generalized myasthenia gravis.

M & A Rare Diseases

Deal Watch: BMS Licenses Bispecific TCR Candidate From Immatics

BioMarin teams with Skyline on gene therapies for cardiovascular disease. Myrtelle discloses licensing of gene therapy for Canavan disease from Pfizer earlier in 2021.

Deal Watch Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Bio-Technology General Corporation
    • Crealta Holdings LLC
    • Crealta Pharmaceuticals
    • Curzion Pharmaceuticals, Inc.
    • Encode Pharmaceuticals, Inc.
    • Horizon Pharma plc
    • Hyperion Therapeutics, Inc. (Andromeda Biotech Ltd)
    • Nitec Pharma AG
    • Raptor Pharmaceutical Corp.
    • River Vision Development Corp.
    • Savient Pharmaceuticals, Inc. (SVNT)
    • TorreyPines Therapeutics, Inc. (Neurogenetics Inc.)
    • Vidara Therapeutics Inc
    • Viela Bio, Inc.
UsernamePublicRestriction

Register